mercredi 8 novembre 2017

Onco Actu du 8 novembre 2017


1. Biologie

NCRI 2017: Understanding cancer evolution [Institute of Cancer Research]

2.6 Etiologie - Environnement

My Wishlist for the New Head of IARC [The Risk-Monger]

Parental exposure to hazardous agents tied to eye tumors in offspring [Reuters]

WHO seeks new director for cancer agency facing U.S. scrutiny [Reuters]

3.3 Prévention - Vaccins

Know what’s worse than the risks of getting the HPV vaccine? Getting an HPV-related cancer. Trust me [STAT]

A doctor writes: We need to talk about oral sex and cancer [Irish Times]

3.7 Prévention - Alcool

Alcohol Linked to Cancer According to Major Oncology Organization: ASCO Cites Evidence and Calls for Reduced Alcohol Consumption [ASCO]

Cancer Doctors Cite Risks of Drinking Alcohol [NY Times]

Cutting back on alcohol can prevent cancers: experts [Reuters]

4.9 Dép., diag. & prono. - Sein

Breast cancer – can prevention become more personalised? [PHG Foundation]

5. Traitements

Study Tracks the Evolution of Treatment Resistance in Metastatic Breast Cancer [NCI]

5.12 Immunothérapies

Cancer treatment response may be affected by gut bacteria [NHS Choices]

5.12.2 Immunothérapies - CAR-T

CAR T-Cell Therapy: Is It Right For You? [Dana-Farber Cancer Institute]

FDA Lifts Hold on Cellectis’s “Off the Shelf” CAR-T, With Caveats [Xconomy]

5.12.3 Immunothérapies-combinaisons

Opdivo Plus Yervoy Combination Delivered Overall Survival Benefit Across PD-L1 Expression Levels in Intermediate- and Poor-Risk Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma [BMS]

5.12.9 Immunothérapies - SITC

Acess SITC 2017 Abstracts [The Sentinel]

Bristol-Myers Squibb to Highlight Clinical and Translational Research at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting [BMS]

5.2 Pharma

Novartis reports positive results from Phase III trial of Kisqali® (ribociclib) combination therapy in premenopausal women with HR+/HER2- advanced or metastatic breast cancer [Novartis]

Novartis cancer drug Kisqali succeeds in late-stage trial [Rfeuters]

5.2.2 Pharma - Fusions & Acquisitions

Say it with us: IQVIA is the new Quintiles and IMS Health [EndPoints]

5.2.3 Pharma - économie

2,300 Lilly Workers, Many In Indiana, Take Buyouts Amid Downsizing [WFYI]

5.3 Traitements - FDA, EMA, NICE...

EMA gets ready for relocation decision [EMA]

5.3.4 Traitements - AMM (FDA, EMA)

With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer [FiercePharma]

6.1 Observation

Thousands living with advanced cancer, says Macmillan [BBC News]

NCDS, health equity and social determinants of health [Marmot Review]

Thousands with advanced cancer are surviving two years or more, data shows [The Guardian]

IUDs may cut risk of cervical cancer by a third, study indicates [The Guardian]

Mongolia's liver cancer crisis: 'No other country has a problem like this' [The Guardian]

6.10 Politiques

Brexit with no deal risks chaos in drug supply, report warns [Reuters]

6.10.1 Politiques (USA)

Ohio voters reject measure to rein in drug costs [STAT]

6.6 Publications

Pirate paper website Sci-Hub dealt another blow by US courts [Nature]